Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Medical News Article on Prostate Cancer
Research conducted at University of Tampere has provided new information about prostate cancer
2009 JUN 29 -- A new study, 'C-reactive proteinhaplotype is associated with high PSA as a marker of metastaticprostate cancer but not with overall cancer risk,' is now available. According to a study from Tampere, Finland, "Growing evidence points to a role for inflammation in prostatecarcinogenesis. The significance of C-reactive protein (CRP), an inflammatory and innate immunitymolecule, has not been evaluated thoroughly in prostate cancer (PC)."
"In this study of 739 Finnish patients with PC and 760 healthy men, we evaluated the associations of CRP genotypes and haplotypes with total PC risk and PC progression, using prostate-specific antigen...
In order to view the entire article, please read your options to the right
